Examining changes in personality following shamanic ceremonial use of ayahuasca.
Brandon Weiss, Joshua D. Miller, Nathan T. Carter, W. Keith Campbell
Scientific Reports March 23, 2021 DOI: 10.1038/s41598-021-84746-0 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 256 |
| Population | Participants from three ayahuasca healing and spiritual centers in South and Central America |
| Intervention | Ayahuasca |
| Duration | Baseline to post-ceremony and 3-month follow-up |
| Topics | Ayahuasca Shamanism |
| Keywords | Psychedelics Entheogens Shamanic medicine Personality change Personal growth Self-improvement Trait alteration Psychological transformation Mental health Psychological health Enhanced well-being Indigenous practices Spiritual ceremonies |
| Citations | 80 |
| Key findings | Ceremonial ayahuasca use was associated with a large reduction in Neuroticism, as measured by both self-report and informant-report. |
Abstract
Abstract The present study examines the association between the ceremonial use of ayahuasca—a decoction combining the Banistereopsis caapi vine and N,N-Dimethyltryptamine-containing plants—and changes in personality traits as conceived by the Five-Factor model (FFM). We also examine the degree to which demographic characteristics, baseline personality, and acute post-ayahuasca experiences affect personality change. Participants recruited from three ayahuasca healing and spiritual centers in South and Central America (N = 256) completed self-report measures of personality at three timepoints (Baseline, Post, 3-month Follow-up). Informant-report measures of the FFM were also obtained (N = 110). Linear mixed models were used to examine changes in personality and the moderation of those changes by covariates. The most pronounced change was a reduction in Neuroticism dz self-reportT1–T2 = − 1.00; dz self-reportT1–T3 = − .85; dz informant-reportT1–T3 = − .62), reflected in self- and informant-report data. Moderation of personality change by baseline personality, acute experiences, and purgative experiences was also observed.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
State of the evidence: Shamanism Supports
Ceremonial ayahuasca use was associated with a large reduction in Neuroticism on self-report (dz = -1.00 at post, -0.85 at 3-month follow-up) and informant-report (dz = -0.62 at follow-up), with moderation by baseline personality, acute experiences, and purgative experiences.
Synthesized
Comparable studies
Other observational and cohort studies on shamanism, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Ayahuasca Tourism: Participants in Shamanic Rituals and their Personality Styles, Motivation, Benefits and Risks Foreigners who traveled to South America to use ayahuasca | 2015 | Observational study | n = 77 |
| New mescaline concentrations from 14 taxa/cultivars of Echinopsis spp. (Cactaceae) (“San Pedro”) and their relevance to shamanic practice 14 taxa/cultivars of Echinopsis (Cactaceae) subgenus Trichocereus | 2010 | Observational study | n = 14 |
| Neural Correlates of the Shamanic State of Consciousness Shamanic practitioners and healthy controls | 2021 | Observational cohort | n = 48 |
| The experience of altered states of consciousness in shamanic ritual: the role of pre-existing beliefs and affective factors. Participants in a sweat lodge ceremony | 2010 | Observational study | n = 55 |
| Long-term outcomes of shamanic treatment for temporomandibular joint disorders. Women aged 25 to 55 diagnosed with TMD | 2012 | Phase I feasibility and efficacy study with longitudinal follow-up | n = 23 |
Citations in the library
Cited by 67
- Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials Psychopharmacology April 1, 2022
- The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world Psychopharmacology August 8, 2022
- Canalization and plasticity in psychopathology Neuropharmacology December 27, 2022
- Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression. Psychological Medicine June 1, 2024
- Expectancy Effects in Psychedelic Trials. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging May 1, 2024
and 62 more in the library
Cites 34
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology November 8, 2017
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology December 1, 2011
and 29 more in the library